OREANDA-NEWS. lmmuDyne announced today its financial results for the quarter ended June 30, 2016 and provided an update on its interim results for the first six weeks of Q3 2016.

"We are pleased with our growth. Net sales increased 343% to $1.227 million, driven predominately by our direct response marketing expansion.  Adjusted net income improved to $109,720 from adjusted net loss of ($19,028) in the previous year. For the remainder of 2016, we are forecasting further, elevated revenue growth, along with improving margins. We continue to operate responsibly in support of our compelling opportunities," stated Mark McLaughlin, CEO and President of lmmuDyne.

About lmmuDyne

lmmuDyne, Inc. (the "Company") is a health and wellness company which develops, manufactures, markets, and sells innovative lifestyle products. The Company's lead products contain its proprietary yeast beta glucans that have been shown through testing and analysis to support the immune system. The Company's products include once a day oral intake capsules as well as topical serums and creams for skin application. lmmuDyne also has developed a proprietary natural delivery technology for potential new market opportunities. All of lmmuDyne's intellectual property is protected by patents and/or trade secrets.